Avacta Group PLC - Asset Resilience Ratio

Latest as of June 2021: 8.33%

Avacta Group PLC (AVCT) has an Asset Resilience Ratio of 8.33% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX5.02 Million

≈ $611.15 USD Cash + Short-term Investments

Total Assets

GBX60.31 Million

≈ $7.34K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2020)

This chart shows how Avacta Group PLC's Asset Resilience Ratio has changed over time. Check AVCT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Avacta Group PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Avacta Group PLC market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX5.02 Million	8.33%
Total Liquid Assets	GBX5.02 Million	8.33%

Asset Resilience Insights

Limited Liquidity: Avacta Group PLC maintains only 8.33% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Avacta Group PLC Industry Peers by Asset Resilience Ratio

Compare Avacta Group PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	57.90%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Theravance Biopharma Inc F:0TB	Biotechnology	37.29%

Annual Asset Resilience Ratio for Avacta Group PLC (2016–2020)

The table below shows the annual Asset Resilience Ratio data for Avacta Group PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	29.67%	GBX20.02 Million ≈ $2.44K	GBX67.46 Million ≈ $8.21K	+16.99pp
2017-07-31	12.68%	GBX4.00 Million ≈ $486.68	GBX31.55 Million ≈ $3.84K	-13.95pp
2016-07-31	26.63%	GBX10.00 Million ≈ $1.22K	GBX37.55 Million ≈ $4.57K	--

pp = percentage points

About Avacta Group PLC

LSE:AVCT UK Biotechnology

Market Cap

$3.62 Million

GBX29.76 Billion GBX

Market Cap Rank

#29131 Global

#549 in UK

Share Price

GBX68.00

Change (1 day)

-0.73%

52-Week Range

GBX43.25 - GBX89.00

All Time High

GBX274.91